Business and Finance Business and Finance
Sun, January 19, 2025
[ 11:40 AM ] - MSN
Biden's economic legacy: Historic wage gains, investment and job growth but marred by inflation
[ 11:40 AM ] - AOL
4 Breakout Growth Stocks You Can Buy and Hold for the Next Decade
[ 11:00 AM ] - Reuters
Santander considers UK exit amid frustrations with high street banking, FT reports
[ 10:01 AM ] - MSN
About The Wall Street Journal Economic Forecasting Survey
[ 10:00 AM ] - AOL
Trump is promising to cut government red tape for businesses. He could also add to it.
[ 09:00 AM ] - MSN
10 Things You Should Stop Buying To Save More Money
[ 08:40 AM ] - BBC
UK and EU look to 2025 for reset, but with little room for trade-offs
[ 07:41 AM ] - AOL
Should You Buy the Dip in Eli Lilly Stock Right Now?
[ 07:40 AM ] - Kiplinger
2025 Stocks Forecast: What Stock Pros Expect This Year
[ 07:21 AM ] - AOL
Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year
[ 07:21 AM ] - Forbes
What Are Altcoins? A Guide For Investors
[ 07:21 AM ] - Forbes
How Financial Planning Has Got The Story All Wrong: Insights From StoryBrand's Donald Miller
[ 07:20 AM ] - Mint
Your guide to investing in the US and global stocks through the Liberalized Remittance Scheme
[ 06:40 AM ] - MSN
Weekly Horoscope Pisces, January 19-25, 2025 predicts a positive outcome
[ 06:21 AM ] - MSN
Is Amazon a Buy, Sell, or Hold in 2025?
[ 05:21 AM ] - MSN
RTO mandates are showing a trust breakdown between bosses and workers
[ 05:21 AM ] - MSN
Centre makes 'Master Plan' to break dominance of .. irtel, Vodafone to..., Modi government decides...
[ 05:20 AM ] - MSN
Weekly Money Horoscope January 19 to January 25, .. pending, saving, and earning for all zodiac signs
[ 04:41 AM ] - MSN
3 Reasons to Buy Walmart Stock in 2025
[ 04:40 AM ] - MSN
2 Magnificent Growth Stocks That Can Outperform the S&P 500
[ 02:00 AM ] - NDTV
Beginners Guide To Union Budget: A Financial Document For The Year Ahead
[ 12:20 AM ] - SunLive
Prime Minister unveils cabinet changes
Sat, January 18, 2025
[ 11:40 PM ] - TechCrunch
EV startup Canoo files for bankruptcy and ceases operations
[ 11:00 PM ] - Truthout
Trump Is Packing His Cabinet With Crypto, Oil and Private Prison Profiteers
[ 10:40 PM ] - MARCA
IRS confirms tax relief for California wildfire victims: Here's what you need to know
[ 08:20 PM ] - Couriermail
Beloved Sydney cafe Khamsa Eatery closes after eight years citing landlord dispute
[ 06:21 PM ] - blockonomi
Top 3 AI Altcoins for Q1 2025 That Could Deliver a Life-Changing 50,000% ROI
[ 06:20 PM ] - businessday
Airtel Africa, BUA Foods, 11 others top trillion-naira club
[ 06:20 PM ] - Reuters
Bank of America awards stock to employees after strong 2024 performance, memo shows
[ 06:00 PM ] - Investopedia
10 Ways to Improve Cash Flow in Construction

Should You Buy the Dip in Eli Lilly Stock Right Now?


Published on 2025-01-19 07:41:00 - AOL
  Print publication without navigation

  • All told, Lilly stock still gained 33% in 2024, outperforming the S&P 500 and Nasdaq Composite. Unfortunately, Lilly investors haven't had much to celebrate so far in 2025. On Jan. 14, shares of Lilly dropped by as much as 8% and ended the day down around 6%. Year-to-date, share prices are down about 1.4%.

The article from AOL Finance discusses whether it's a good time to invest in Eli Lilly stock following a recent dip. Eli Lilly, a major pharmaceutical company, has experienced a decline in its stock price despite positive developments such as the FDA approval of its Alzheimer's drug, Donanemab, and strong sales of its diabetes drug, Mounjaro. The article highlights that while the stock has fallen, Eli Lilly's future looks promising due to its robust pipeline of new drugs and treatments. Analysts suggest that the dip could be an opportunity for long-term investors, given the company's potential for growth, its innovation in treatments for obesity, diabetes, and Alzheimer's, and its consistent performance in earnings. However, the article also notes concerns like competition, pricing pressures, and regulatory challenges that could impact future performance. Overall, the consensus seems to lean towards buying the dip, with the belief that Eli Lilly's long-term prospects remain strong.

Read the Full AOL Article at:
[ https://www.aol.com/finance/buy-dip-eli-lilly-stock-100500713.html ]
Contributing Sources